Hot, excluded and cold tumor patterns
In one sentence
Hot, excluded and cold describe patterns of immune-cell presence and location in sampled tumor tissue, rather than proving tumor recognition or treatment benefit.
The intuition
Imagine looking at a building: people may be inside, gathered outside or scarce throughout. That tells you something about access. It does not tell you why they came or what they are doing. Tumor immune patterns carry the same limit.
How it works
These patterns commonly emphasize where T cells are found. Other immune-cell populations need their own identities and counts; a macrophage-rich sample is not automatically T-cell inflamed.
An inflamed, often called hot, pattern has immune cells within sampled tumor regions. An excluded pattern has cells concentrated in surrounding tissue or at a boundary, with less entry into cancer-cell areas. An immune-desert pattern has few relevant immune cells in the examined regions. “Cold” is used inconsistently: some writers mean desert; others include excluded tumors. State which meaning you are using. The cancer–immune set-point framework describes these patterns.
| Pattern | Observation | What remains open |
|---|---|---|
| Inflamed or hot | Immune cells reach sampled tumor regions | Their targets, function and treatment responsiveness |
| Excluded | Immune cells concentrate outside cancer-cell regions | Which barrier or signal limits entry |
| Desert | Few relevant immune cells are seen | Whether priming, recruitment, sampling or another factor explains scarcity |
Different tumor regions or disease sites can have different patterns. A small biopsy gives a window, not a census of all cancer. Treatment can change the sampled environment. Timing and location belong beside the label.
Presence also differs from specificity. Some cells in a tumor respond to infections or other antigens. Others restrain immune activity. “Hot” therefore does not mean every visible T cell is attacking cancer. Conversely, few visible cells do not show that no immune response exists elsewhere.
Why it matters in cancer
The pattern helps organize questions about priming, recruitment, access and local function. It can motivate more measurement. It does not by itself select a vaccine, checkpoint drug or treatment combination.
Worked example
A fictional biopsy has many lymphocytes in surrounding stroma but few inside cancer-cell nests. “Immune-rich stroma” describes the observation. Calling it effective tumor killing goes beyond the image. Calling the whole patient immune-excluded may also be too broad if other sites were not sampled.
Common confusions
- Hot is not synonymous with tumor-specific or effective.
- Exclusion describes distribution, not a proven physical-wall mechanism.
- A stromal score and an intratumoral-cell count have different denominators.
- There is no universal hot/cold threshold shared by every assay and cancer.
How it is measured
Routine pathology counts or scores cells under specified rules. Multiplex imaging distinguishes cell identities and locations. Gene-expression profiles describe mixed activity programs but usually lose direct location. The immune-readout lesson explains how the layers fit together. Breast-cancer stromal lymphocyte guidelines define a particular scoring method, rather than a universal hot/cold test. The working-group recommendations give that scope.
Related concepts
Sources and scope
Source check: October 9, 2026. Descriptive tissue patterns; clinical predictions require assay-, population- and treatment-specific evidence. Expert and learner review remain pending.
- Chen and Mellman, 2017: immune profiles in the cancer–immune set-point framework.
- Salgado et al., 2015: breast-cancer lymphocyte-scoring recommendations.
- Kos et al., 2020: variability and pitfalls in stromal lymphocyte assessment.